Best Tumor marker CA 15-3 Doctors Worldwide — TOP 15

Dr. Mustafa Solak is a clinical oncologist at Hisar Hospital Intercontinental. He monitors breast cancer cases using the CA 15-3 diagnostic marker.

• Trained at the University of Texas MD Anderson Cancer Center in the USA
• Completed an advanced oncology fellowship at Hacettepe University Cancer Institute
• Specializes in systemic therapies including immunotherapy with Keytruda and targeted treatments
• Member of the medical team at Hisar Hospital – a major JCI-accredited facility

Dr. Suleyman Hilmi Aksoy is an Assistant Professor at Cerrahpasa Medical Faculty. He uses imaging to guide complex diagnostic evaluations at Hisar Hospital Intercontinental.

• Specializes in interventional radiology to perform minimally invasive diagnostic procedures
• Performs mammography with tomosynthesis to create detailed images of breast tissue
• Member of the European Society of Radiology and International Society of Radiology
• Presented research at thirteen national and international medical congresses
• Provides whole-body imaging for CA 15-3 diagnostic monitoring

Professor Tahsin Ozatli is an oncology specialist at Istinye University Liv Hospital Bahcesehir. He uses the CA 15-3 tumor marker to monitor breast cancer patients.

• Promoted to Associate Professor in 2016 for his academic and clinical work
• Specializes in treating breast, lung, and gastrointestinal cancers
• Trained at the Ankara Oncology Clinic, a major cancer research hub
• Previously worked at the Erzurum Regional Training and Research Hospital
• Studied medicine at Selcuk University in Konya, Turkey

Dr. Elnur Sahibov is a radiation oncology specialist at Emsey Hospital. He uses his oncology background to help interpret tumor marker CA 15-3 results.

• Specialized in radiation oncology at Marmara University Faculty of Medicine
• Practices at Emsey Hospital – a major private medical center in Turkey
• Focuses on cancer care and diagnostic monitoring through blood tests
• Completed medical training in English at Marmara University

Dr. Antonio Cubillo Gracián leads the Medical Oncology Service at HM Sanchinarro. He pioneered a liquid biopsy program for molecular tumor analysis in Spain.

• Heads the Medical Oncology Service at Hospital Universitario HM Sanchinarro
• Specializes in using molecular markers to design targeted cancer treatment plans
• Director of Postgraduate Research at HM CIOCC USP CEU
• Co-investigator for the Start Madrid oncology clinical trials program
• Specialist in tumors of the digestive system and lung cancer

Professor Kayihan Engin is the Director of Oncological Sciences at Medicana Bursa Hospital. He manages advanced breast cancer cases where CA 15-3 tumor marker testing is vital for monitoring.

• Completed a post-doctoral fellowship at Thomas Jefferson University in the USA
• Former Chairman of Radiation Oncology at Uludağ University Medical College
• Specializes in thermoradiotherapy – using heat to make cancer cells more sensitive to treatment
• Expert in CyberKnife – a robotic system delivering radiation with pinpoint accuracy
• Coordinated oncological programs at Anadolu Medical Center for 13 years

Dr. Sridhar P.S. is a specialist in radiation oncology at HCG Manavata Cancer Centre. He focuses on cancer detection and monitoring using tools like the Tumor marker CA 15-3.

• Earned a Doctor of Medicine in radiotherapy from Banaras Hindu University
• Holds a Diplomate of National Board certification in radiotherapy
• Member of the Indian Association of Hyperthermia Oncology
• Belongs to the Society for Neuro-Oncology for brain tumor expertise
• Active in the Association of Radiation Oncology of India

Dr. Chaitainya Borde has handled more than 30,000 PET scans at HCG Manavata Cancer Centre. He integrates CA 15-3 tumor marker testing with advanced nuclear imaging for breast cancer monitoring.

• Specializes in nuclear medicine – provides expert interpretation of complex diagnostic scans
• Experienced in PET-CT scans for precise cancer staging and monitoring
• Treated 1,000 thyroid cancer patients using targeted radioisotope therapies
• Published research papers on diagnostic accuracy in various medical journals

Dr. Shruti Kate is a medical oncology specialist at HCG Manavata Cancer Centre. She provides expert consultation on breast cancer markers including CA 15-3.

• Trained at Tata Memorial Hospital – India's premier cancer treatment and research center
• Presented lung cancer research at the 2018 World Conference in Toronto
• Member of ASCO and ESMO to ensure international medical standards
• Specializes in immunotherapy and metronomic therapy for aggressive cancers
• Recieved the National Travel Award for her contributions to oncology research

Dr. Ahmer Arif Shaikh holds a fellowship in Head and Neck Surgical Oncology. He works at the NABH-accredited HCG Manavata Cancer Centre during tumor marker CA 15-3 evaluations.

• Treats oral and maxillofacial cancers using organ preservation techniques
• Performs lymphadenectomy to check if cancer has spread to local lymph nodes
• Former researcher with publications in several national and international medical journals
• Master of Dental Surgery from Rajasthan University of Health Sciences
• Focuses on early diagnosis for improved patient functional rehabilitation

10,000 major surgeries performed – Dr. Lalit Banswal is a leading surgical oncologist at HCG Manavata Cancer Centre.

• Performed over 10,000 major operations on complex cancer cases
• Fellowship trained in surgical oncology at Tata Medical Centre in Kolkata
• Served as head investigator for clinical research at Tata Medical Center
• Assistant Professor at the State Cancer Institute and Government Cancer Hospital
• Uses CA 15-3 marker screening to help monitor breast cancer status

Dr. Shaunak Valame specializes in molecular oncology at the HCG Manavata Cancer Centre. He uses tumor marker CA 15-3 to monitor breast cancer treatment and track patient progress.

• Trained in medical oncology at Indraprastha Apollo Hospital in New Delhi
• Member of the American Society of Clinical Oncology (ASCO)
• Presented stomach cancer research at the 2020 ASCO Symposium in San Francisco
• Focuses on targeted therapies for breast, gynecological, and solid tumors
• Performs supportive procedures like port insertions for chemotherapy delivery

With 50,000+ cancer surgeries performed, Dr. Nagarkar is the Chief of Surgical Oncology at HCG Manavata Cancer Centre. He uses the tumor marker CA 15-3 to monitor breast cancer treatment.

• Specializes in breast surgical oncology after training at the prestigious Tata Memorial Hospital
• Member of the Royal College of Surgeons of Edinburgh in the UK
• Professor for DNB Superspecialty Surgical Oncology – trains the next generation of cancer surgeons
• Contributed to 200+ clinical trials testing new protocols for various cancer types